These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21716071)

  • 1. HIV infection perturbs interleukin-7 signaling at the step of STAT5 nuclear relocalization.
    Landires I; Bugault F; Lambotte O; de Truchis P; Slama L; Danckaert A; Delfraissy JF; Thèze J; Chakrabarti LA
    AIDS; 2011 Sep; 25(15):1843-53. PubMed ID: 21716071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-7-dependent STAT-5 activation and CD8+ T cell proliferation are impaired in HIV infection.
    Vranjkovic A; Crawley AM; Patey A; Angel JB
    J Leukoc Biol; 2011 Apr; 89(4):499-506. PubMed ID: 21177484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell signalling in antiretroviral-treated, aviraemic HIV-1-positive individuals is present in a raised state of basal activation that contributes to T-cell hyporesponsiveness.
    Downey JS; Attaf M; Moyle G; Gazzard B; Gotch F; Imami N
    AIDS; 2011 Oct; 25(16):1981-6. PubMed ID: 21811141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-7 and the HIV Tat protein act synergistically to down-regulate CD127 expression on CD8 T cells.
    Faller E; Kakal J; Kumar R; Macpherson P
    Int Immunol; 2009 Mar; 21(3):203-16. PubMed ID: 19147839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Despite an impaired response to IL-7, CD4+EM T cells from HIV-positive patients proliferate normally in response to IL-15 and its superagonist, RLI.
    Pacheco Y; Solé V; Billaud E; Allavena C; Plet A; Ferré V; Garrigue-Antar L; Raffi F; Jacques Y; McIlroy D
    AIDS; 2011 Sep; 25(14):1701-10. PubMed ID: 21673554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patients.
    Keh CE; Shen JM; Hahn B; Hallahan CW; Rehm CA; Thaker V; Wynne SM; Davey RT; Lane HC; Sereti I
    AIDS; 2006 Feb; 20(3):361-9. PubMed ID: 16439869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A steady state of CD4+ T cell memory maturation and activation is established during primary subtype C HIV-1 infection.
    Maenetje P; Riou C; Casazza JP; Ambrozak D; Hill B; Gray G; Koup RA; de Bruyn G; Gray CM
    J Immunol; 2010 May; 184(9):4926-35. PubMed ID: 20363974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual mechanism of impairment of interleukin-7 (IL-7) responses in human immunodeficiency virus infection: decreased IL-7 binding and abnormal activation of the JAK/STAT5 pathway.
    Juffroy O; Bugault F; Lambotte O; Landires I; Viard JP; Niel L; Fontanet A; Delfraissy JF; Thèze J; Chakrabarti LA
    J Virol; 2010 Jan; 84(1):96-108. PubMed ID: 19864382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low CD4 T-cell counts despite low levels of circulating HIV: insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease.
    Albuquerque AS; Foxall RB; Cortesão CS; Soares RS; Doroana M; Ribeiro A; Lucas M; Antunes F; Victorino RM; Sousa AE
    Clin Immunol; 2007 Oct; 125(1):67-75. PubMed ID: 17692571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-specific IL-21 producing CD4+ T cells are induced in acute and chronic progressive HIV infection and are associated with relative viral control.
    Yue FY; Lo C; Sakhdari A; Lee EY; Kovacs CM; Benko E; Liu J; Song H; Jones RB; Sheth P; Chege D; Kaul R; Ostrowski MA
    J Immunol; 2010 Jul; 185(1):498-506. PubMed ID: 20519650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional patterns of HIV-1-specific CD4 T-cell responses in children are influenced by the extent of virus suppression and exposure.
    Correa R; Harari A; Vallelian F; Resino S; Munoz-Fernandez MA; Pantaleo G
    AIDS; 2007 Jan; 21(1):23-30. PubMed ID: 17148964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-7 signalling defects in naive CD4+ T cells of HIV patients with CD4+ T-cell deficiency on antiretroviral therapy are associated with T-cell activation and senescence.
    Tanaskovic S; Fernandez S; Price P; French MA
    AIDS; 2014 Mar; 28(6):821-30. PubMed ID: 24499954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiparametric flow cytometric analysis of signal transducer and activator of transcription 5 phosphorylation in immune cell subsets in vitro and following interleukin-2 immunotherapy.
    Varker KA; Kondadasula SV; Go MR; Lesinski GB; Ghosh-Berkebile R; Lehman A; Monk JP; Olencki T; Kendra K; Carson WE
    Clin Cancer Res; 2006 Oct; 12(19):5850-8. PubMed ID: 17020993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART.
    Marziali M; De Santis W; Carello R; Leti W; Esposito A; Isgrò A; Fimiani C; Sirianni MC; Mezzaroma I; Aiuti F
    AIDS; 2006 Oct; 20(16):2033-41. PubMed ID: 17053349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of interleukin-7 receptor (CD127) in HIV infection is associated with T cell activation and is a main factor influencing restoration of CD4(+) cells after antiretroviral therapy.
    Benito JM; López M; Lozano S; González-Lahoz J; Soriano V
    J Infect Dis; 2008 Nov; 198(10):1466-73. PubMed ID: 18847371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individuals.
    Moir S; Ogwaro KM; Malaspina A; Vasquez J; Donoghue ET; Hallahan CW; Liu S; Ehler LA; Planta MA; Kottilil S; Chun TW; Fauci AS
    Proc Natl Acad Sci U S A; 2003 May; 100(10):6057-62. PubMed ID: 12730375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiretroviral therapy-induced dominant interleukin-2 HIV-1 Gag CD4+ T cell response: evidence of functional recovery of HIV-1-specific CD4+ T cells.
    Tsalimalma K; Kordossis T; Choremi-Papadopoulou E
    Scand J Immunol; 2011 Mar; 73(3):256-65. PubMed ID: 21204901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD38 identifies a hypo-proliferative IL-13-secreting CD4+ T-cell subset that does not fit into existing naive and memory phenotype paradigms.
    Scalzo-Inguanti K; Plebanski M
    Eur J Immunol; 2011 May; 41(5):1298-308. PubMed ID: 21469087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.